Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition

Hanadi Ajam Oughli, Marie Anne Gebara, Adam Ciarleglio, Helen Lavretsky, Patrick J. Brown, Alastair J. Flint, Nuri B. Farber, Jordan F. Karp, Benoit H. Mulsant, Charles F. Reynolds, Steven P. Roose, Lei Yang, Meryl A. Butters, Eric J. Lenze